Treatment of chronic hepatitis B with lamivudine in renal allograft recipients.
Lewandowska
D
D
Transplantation Institute, Medical University of Warsaw, Warsaw, Poland.
Durlik
M
M
Kukuła
K
K
Cieciura
T
T
Ciecierski
R
R
Walewska-Zielecka
B
B
Szmidt
J
J
Rowiński
W
W
Lao
M
M
D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D001706:Biopsy; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D016030:Kidney Transplantation; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications
D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D019259:Lamivudine